跳至主要内容
临床试验/NCT04771767
NCT04771767Unknown2 期

Assessing a Combined Ketamine and Online Cognitive Behavioural Therapy Intervention for Treatment Resistant Post-Traumatic Stress Disorder

Queen's University1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2021年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
16
试验地点
1
主要终点
Change in Scores on the Clinician Administered PTSD Scale for DSM-5

研究概览

简要总结

An open label RCT assessing the efficacy of a combined treatment approach for PTSD, using Ketamine infusions and online Cognitive Behavioural Therapy.

详细描述

OBJECTIVES

(i) To introduce a previously untreated patient population with PTSD to new therapeutic options.

(ii) To provide new insights into the functional role of Glutamate in affective disorders as well as in learning and memory.

(iii) To explore the utility of pharmacologically-enhanced psychotherapy.

OUTLINE

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of PTSD by a psychiatrist on the team using the Clinician Administered PTSD Scale (CAPS-5) with a score of at least 50 and a medium presentation.
  • Patients will have received at least 2 different types of prior treatment, both of which produced less than a 50% reduction in the participant's symptoms.
  • Participants with hypertension or cardiovascular disease must be receiving stable treatment to participate.
  • Participants must speak and read English, and will have consistent and reliable access to the internet.
  • Patients with suicidal ideation will be included.
  • Patients with a history of substance abuse will be included (except for opioid use disorder).

排除标准

  • Hypomanic/manic episodes, bipolar disorder, acute psychosis, opioid use disorder, treatment with Naltrexone, pregnancy, postpartum, breastfeeding, untreated hypertension, cardiovascular disease, ASPD, active homicidal ideation, and general noncompliance with the study protocol.

研究组 & 干预措施

Ketamine + eCBT

Experimental

Over 12 weeks, participants receive weekly sessions of asynchronous online cognitive-behavioural therapy as well as 6 sub-anesthetic infusions of Ketamine

干预措施: Ketamine (Drug)

Ketamine + eCBT

Experimental

Over 12 weeks, participants receive weekly sessions of asynchronous online cognitive-behavioural therapy as well as 6 sub-anesthetic infusions of Ketamine

干预措施: Online Trauma-Focused Cognitive Behavioural Therapy (Behavioral)

结局指标

主要结局

Change in Scores on the Clinician Administered PTSD Scale for DSM-5

时间窗: 0 weeks from start, 4 weeks from start, 8 weeks from start, and 12 weeks from start

Assessment of PTSD symptoms for diagnosis and severity; score representing the mildest/lack of symptoms: 0; score representing the most severe symptoms: 120.

次要结局

  • Change in Scores on the Montgomery Asberg Depression Rating Scale(0 weeks from start, 4 weeks from start, 8 weeks from start, and 12 weeks from start)
  • Change in Scores on the Columbia Suicide Severity Rating Scale(0 weeks from start, 4 weeks from start, 8 weeks from start, and 12 weeks from start)
  • Change in Scores on the Sheehan Disabilities Scale(0 weeks from start, 4 weeks from start, 8 weeks from start, and 12 weeks from start)
  • Change in Scores on the Global Assessment of Functioning(0 weeks from start, 4 weeks from start, 8 weeks from start, and 12 weeks from start)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Taras Reshetukha

Principle Investigator

Queen's University

研究点 (1)

Loading locations...

相似试验